A detailed history of Jt Stratford LLC transactions in Mannkind Corp stock. As of the latest transaction made, Jt Stratford LLC holds 50,254 shares of MNKD stock, worth $254,285. This represents 0.04% of its overall portfolio holdings.

Number of Shares
50,254
Previous 33,873 48.36%
Holding current value
$254,285
Previous $126,000 113.49%
% of portfolio
0.04%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$3.42 - $5.74 $56,023 - $94,026
16,381 Added 48.36%
50,254 $269,000
Q2 2025

Aug 13, 2025

BUY
$3.71 - $5.04 $125,668 - $170,719
33,873 New
33,873 $126,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.3B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Jt Stratford LLC Portfolio

Follow Jt Stratford LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jt Stratford LLC with notifications on news.